52 results
Page 2 of 3
10-K
iz9gh
29 Jun 20
Annual report
4:02pm
S-3
EX-5.1
z5dffdhqbwgt41c2xws
29 Jun 20
Shelf registration
12:00am
S-3
EX-1.2
lben5h
29 Jun 20
Shelf registration
12:00am
6-K
EX-99.1
wlhrt691sto0yb3anae
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
ubldj5kcckm9
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
8ox4ua
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
0uqafinf
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
F-3
EX-4.6
yiruncl6e8
7 Aug 19
Shelf registration (foreign)
12:00am
F-3
EX-5.1
bwv73e8hp7
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
0348nk0u1bs8
14 Feb 19
At Market Issuance Sales Agreement
8:13am
6-K
EX-99.1
54bj0w620jnt17610apf
9 Oct 18
Current report (foreign)
5:21pm
6-K
EX-99.1
3uimueks3jsk03icn0r
14 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
ny3vtjf5i4wf60n ncg
15 Jul 14
Current report (foreign)
12:00am
20-F
2ef cj3h7250xukf
6 Jun 14
Annual report (foreign)
12:00am
6-K
EX-99.1
mzh 95pkhtnd9m7rz
30 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
lmsv9i hfflyhvev
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
r5z7jhar tdqpgfl0
29 Apr 14
Current report (foreign)
12:00am